Skip to main content

Table 1 Demographic and clinical characteristics

From: Use of the right internal mammary artery and the great saphenous vein for left anterior descending artery revascularization in patients whose left internal mammal artery cannot be used: a study based on transit-time flow measurement

 

LIMA-LAD (333)

RIMA-LAD (34)

SVG-LAD (43)

P

Male (n, %)

241(72.37)

29(85.29)

30(69.77)

0.110

Age

64.27 ± 10.70

56.85 ± 11.01

70.47 ± 10.25

0.000

BMI

26.64 ± 20.25

25.55 ± 2.51

23.79 ± 3.09

0.616

Hypertension (n, %)

209(62.76)

21(61.76)

27(62.79)

0.152

Diabetes (n, %)

141(42.34)

13(38.24)

17(39.53)

0.036

Hyperlipidemia (n, %)

145(43.54)

15(44.12)

19(44.19)

0.455

Previous stroke (n, %)

50(15.01)

9(26.47)

6(13.95)

0.158

COPD (n, %)

7(2.10)

1(2.94)

2(4.65)

0.451

PVD (n, %)

40(12.01)

6(17.65)

3(8.82)

0.723

Previous infarction (n, %)

65(19.52)

6(17.65)

7(16.28)

0.730

PCI

49(14.71)

6(17.65)

8(18.60)

0.719

Number of anastomosis

3.04 ± 0.94

2.78 ± 0.87

3.24 ± 1.07

0.121

NYHA

2.30 ± 0.51

2.33 ± 0.60

2.28 ± 0.51

0.911

LVEF (%, ±s)

62.87 ± 25.18

62.81 ± 9.50

61.40 ± 8.78

0.927

LVEDd (cm, ±s)

50.69 ± 7.034

50.25 ± 6.201

51.43 ± 6.64

0.741

  1. BMI Body mass index, COPD Chronic obstructive pulmonary disease, PVD peripheral vascular diseases, PCI Percutaneous coronary intervention, NYHA New York Heart Association, LVEF left ventricular ejection fraction, LVEDd Left ventricular end-diastolic dimension, LIMA Left internal mammary artery, SVG Great saphenous vein, RIMA Right internal mammary artery, LAD Left anterior descending artery